Forum Home | Log in | Signup | My Page | Rules | FAQ | Boards | Members | Search
« POPE 5 Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next

Re: PSTI - Pluristem Therapeutics

By: Decomposed in POPE 5 | Recommend this post (0)
Thu, 23 Apr 20 9:12 PM | 32 view(s)
Boardmark this board | Pope 5 		Msg. 59689 of 62138
(This msg. is a reply to 59681 by hydro_gen)
Jump:
Jump to board:
Jump to msg. #

hydro_gen:

Re: "And what do you think will generate initial sales from their pipeline to get towards the *multi* _____ worth per year. Which one exactly is applicable to COVID-19 "This sounds a bit dumb, but ALL OF THEM. Pluristem is involved with stem cell treatment for numerous ailments. COVID-19 attacks much of the body, and I think that Pluristem is therefore utilizing most or all of its therapies to help patients. It is "PLX cells" in general that will be the treatment. An excerpt from the company follows.

BTW, the stock is up almost 20% today. Currently $10.64.

PLX cells are available off-the-shelf and once commercialized, can be manufactured in large scale quantities, offering a key advantage in addressing a global pandemic. PLX cells are allogeneic mesenchymal-like cells that have immunomodulatory properties that induce the immune system’s natural regulatory T cells and M2 macrophages, and thus may prevent or reverse the dangerous overactivation of the immune system. Accordingly, PLX cells may potentially reduce the incidence and\or severity of COVID-19 pneumonia and pneumonitis leading hopefully to a better prognosis for the patients. Previous pre-clinical findings of PLX cells revealed therapeutic benefit in animal studies of pulmonary hypertension, lung fibrosis, acute kidney injury and gastrointestinal injury which are potential complications of the severe COVID-19 infection. Clinical data using PLX cells demonstrated the strong immunomodulatory potency of PLX cells in patients post major surgery. Taken together, PLX cells’ potential capabilities with the safety profile observed from clinical trials involving hundreds of patients worldwide potentially position them as a therapy for mitigating the tissue-damaging effects of COVID-19.




Avatar

Gold is $1,581/oz today. When it hits $2,000, it will be up 26.5%. Let's see how long that takes. - De 3/11/2013 - ANSWER: 7 Years, 5 Months

» You can also:
- - - - -
The above is a reply to the following message:
Re: PSTI - Pluristem Therapeutics
By: hydro_gen in POPE 5
Thu, 23 Apr 20 5:54 PM 		Msg. 59681 of 62138

OK it is a rainy day here so I will bite on "I'm a little surprised that you guys don't seem to be seeing this company's potential."

One of MY concerns would be an article posted earlier that there are 30 different strains of COVID-19. Does the treatment offered by PSTI address those mutations OR will another formulation be required???

And what do you think will generate initial sales from their pipeline to get towards the *multi* _____ worth per year. Which one exactly is applicable to COVID-19 and I apologize for not digging deeper. http://www.pluristem.com/clinical-pipeline/

I might pick up a few shares for funsies. I do notice one trait in your two recent stock picks - the letters PIT :-)

Thanks and stay safe everyone!!

« POPE 5 Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next